Please provide your email address to receive an email when new articles are posted on . For the two-part UNIVERSE study, 12 children who underwent the Fontan procedure were enrolled in a single-arm ...

As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. A team from Children's Hospital of ...

The phase 3 UNIVERSE study evaluated rivaroxaban oral suspension in patients aged 2 to 8 years with single ventricle physiology who had the Fontan procedure. New data were announced from a phase 3 ...

Patients who have had surgery to create a Fontan circulation show changes in their genetic code, which may provide a new treatment opportunity to reduce premature aging. The procedure is used to treat ...

PHILADELPHIA — In a phase 3 study, the phosphodiesterase-5 (PDE-5) inhibitor udenafil (Mezzion Pharma) did not improve the primary end point of oxygen consumption at peak exercise, but was associated ...

A multi-center study has identified critical risk factors that increase the likelihood of death in children with a heart defect who are awaiting or have recently undergone heart transplantation, ...

The lifesaving surgery used to treat children with single ventricle heart disease, the Fontan procedure, can pose serious health complications throughout life. The American Heart Association, devoted ...

Patients with Fontan circulatory failure face higher mortality risk while awaiting or after undergoing heart transplantation, if they have certain health complications, according to a multi-center ...

The Fontan procedure has saved the lives of many people born with only one ventricle, but their unique circulatory system requires lifelong medical monitoring and care. A new scientific statement ...

Philadelphia, April 24, 2024 – As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new ...